These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 15462478)

  • 1. [Treatment of patients with high cardiovascular risk in general practice].
    Ilyés I; Erdei I; Jancsó Z
    Orv Hetil; 2004 Aug; 145(33):1723-6. PubMed ID: 15462478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment for hypertension with metabolic disorders (DM etc)].
    Shimamoto K; Miura T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():513-9. PubMed ID: 16981585
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating the "typical" cardiometabolic patient for risk of cardiovascular disease.
    Strobl DJ
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S21-2. PubMed ID: 19451255
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factor management: a practice guide.
    Perk J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S24-8. PubMed ID: 19675433
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular outcomes for obesity and metabolic syndrome.
    Vega GL
    Obes Res; 2002 Nov; 10 Suppl 1():27S-32S. PubMed ID: 12446855
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolic syndrome as a coronary risk factor. Prevention and treatment].
    Kłosiewicz-Latoszek L; Cybulska B
    Kardiol Pol; 2003 Jul; 59(7):59-65. PubMed ID: 14560351
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
    Battista M; Murray RD; Daniels SR
    Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome.
    Virgin SE; Schmitke JA
    AAOHN J; 2003 Jan; 51(1):28-37. PubMed ID: 12596343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
    Després JP
    Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular risk factors and prevention].
    Bongard V; Ferrières J
    Rev Prat; 2006 Jan; 56(1):79-87, 94. PubMed ID: 16548253
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of appropriate patients for cardiometabolic risk management.
    Peters AL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
    Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ;
    Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular risk factors in adolescents: relevance, detection, and intervention.
    McCrindle BW
    Adolesc Med; 2001 Feb; 12(1):147-62. PubMed ID: 11224028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet needs in controlling metabolic disease.
    Haffner SM
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and management of cardiovascular risk in men.
    McBride PE; Ryan G
    Prim Care; 2006 Mar; 33(1):75-91, viii-ix. PubMed ID: 16516681
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic syndrome and cardiovascular disease.
    Citrome L
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):84-93. PubMed ID: 16280341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.